Article
Targeting an RNA Editor to Impede H3K27M+ Pediatric Gliomas
2026-05-12
Abstract excerpt
Diffuse midline glioma (DMG) is a lethal pediatric brain tumor with no curative therapies. Immune checkpoint blockade (ICB) has shown limited efficacy in DMG, largely due to poor T cell infiltration, low immune checkpoint (IC) expression, and a low tumor mutational burden. Here, we identify adenosine deaminase acting on RNA (ADAR), an RNA-editing enzyme that suppresses endogenous dsRNA sensing, as a key mediator o...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c6bc91f3-7735-50b5-a0fc-ac376124a95e
- DOI
- 10.64898/2026.05.08.723800
